Skip to content
RDL Network logo
Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm) — Antonio Palumbo (2008) | RDL Network